The Alliance of Community Health Plans (ACHP) submitted a response to an RFI from the National Institute of Standards and Technology on the exercise of march-in rights. ACHP applauds the government-wide effort to ensure federal agencies are equipped with the necessary guidance and information to exercise march-in rights and secure the federal benefit owed to taxpayers. We strongly encourage the National Institutes of Health to use this framework to take action to utilize march-in rights to lower the cost of prescription drugs.
New from ACHP:
- Overcoming Barriers: Transforming Black Maternal Health Through Research Webinar
- PODCAST: ACHP’s Ceci Connolly Joins Managed Healthcare Executive DC Roundtable Podcast
- OP-ED: What Could We Do if GLP-1 Weight Loss Drugs Were Free? Would Our Obesity Epidemic Be Solved for Good?
- ACHP Statement on Final Rule for Medicare Advantage and Part D
- WEBINAR: Medicare Advantage in 2024 and Beyond
- ACHP Joins First Lady Jill Biden and Health Care Leaders to Support Cancer Moonshot Initiative
